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Interpreting and Managing Blood Lead Levels <10 µg/dL
in Children and Reducing Childhood Exposures to Lead:
Recommendations of CDC’s Advisory Committee
on Childhood Lead Poisoning Prevention
Prepared by
Advisory Committee on Childhood Lead Poisoning Prevention*
Abstract
Lead is a common environmental contaminant, and exposure to lead is a preventable risk that exists in all areas of the United
States. Lead is associated with negative outcomes in children, including impaired cognitive, motor, behavioral, and physical
abilities. In 1991, CDC defined the blood lead level (BLL) that should prompt public health actions as 10 µg/dL. Concurrently,
CDC also recognized that a BLL of 10 µg/dL did not define a threshold for the harmful effects of lead. Research conducted since
1991 has strengthened the evidence that children’s physical and mental development can be affected at BLLs <10 µg/dL.
This report summarizes the findings of a review of clinical interpretation and management of BLLs <10 µg/dL conducted by
CDC’s Advisory Committee on Childhood Lead Poisoning Prevention. This report provides information to help clinicians under-
stand BLLs <10 µg/dL, identifies gaps in knowledge concerning lead levels in this range, and outlines strategies to reduce child-
hood exposures to lead. In addition, this report summarizes scientific data relevant to counseling, blood lead screening, and lead
exposure risk assessment.
To aid in the interpretation of BLLs, clinicians should understand the laboratory error range for blood lead values and, if
possible, select a laboratory that achieves routine performance within ±2 µg/dL. Clinicians should obtain an environmental
history on all children they examine, provide families with lead prevention counseling, and follow blood lead screening recom-
mendations established for their areas. As local and patient circumstances permit, clinicians should consider early referral to
developmental programs for children at high risk for exposure to lead and consider more frequent rescreening of children with
BLLs approaching 10 µg/dL, depending on the potential for exposure to lead, child age, and season of testing. In addition,
clinicians should direct parents to agencies and sources of information that will help them establish a lead-safe environment for
their children. For these preventive strategies to succeed, partnerships between health-care providers, families, and local public
health and housing programs should be strengthened.
Introduction
Lead is a common environmental contaminant, and expo-
sure to lead is a preventable risk in all areas of the United
States. Lead is associated with negative outcomes in children,
including impaired cognitive, motor, behavioral, and physi-
cal abilities (1–4). In 1991, CDC defined the blood lead level
(BLL) that should prompt public health actions as 10 µg/dL.
Concurrently, CDC also recognized that a BLL of 10 µg/dL
did not define a threshold for the harmful effects of lead (5).
Research conducted since 1991 has strengthened the evidence
that children’s physical and mental development can be
affected at BLLs <10 µg/dL (1,3).
During 2002–2004, a workgroup of CDC’s Advisory Com-
mittee on Childhood Lead Poisoning Prevention (ACCLPP)
reviewed the scientific literature regarding adverse health
effects associated with BLLs <10 µg/dL, including 23 pub-
lished reports that analyzed 16 separate populations with
Intelligence Quotient (IQ) or general cognitive index outcomes
and 12 publications related to other health outcomes. In its
2005 report, the workgroup concluded that an inverse asso-
ciation exists between BLLs and cognitive function, with no
evidence of a weaker association in populations with lower
BLLs (1). The direct evidence for this inverse association was
strongest in a study conducted in Rochester, New York, that
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TABLE 1. Blood lead levels (BLLs) of children aged 1–5 years —
National Health and Nutrition Examination Survey,
United States, selected years
% with BLL Geometric mean BLL




included children born in 1994 and1995, enrolled at age 6
months, and followed for 5 years (6). The majority of chil-
dren studied had BLLs <10 µg/dL throughout the study period.
The IQ and blood lead level relationship was most accurately
described by a nonlinear negative association, with a decrease
in IQ of more than seven points over the first 10 µg/dL
increase in lifetime average blood lead concentration. On the
basis of the evidence, the workgroup concluded that a causal
association between lead exposure and impaired cognitive func-
tioning was most likely. However, the potential for residual
confounding, particularly by social factors, made the strength
and shape (i.e., linear or nonlinear) of this association across
BLLs uncertain. In addition, the workgroup concluded that
children with BLLs <10 µg/dL should not be classified as “lead
poisoned.” The report noted that no safe level for blood lead
in children has been identified (1).
Two studies published subsequently have reported negative
effects of BLLs <10 µg/dL on developmental outcomes (7,8).
One study, which included participants from the Rochester
cohort (6) and from six other past prospective studies of chil-
dren with peak BLLs across a range of values, reaffirmed an
inverse association between lead at low levels and IQ (7). In
these studies, key potential confounders were accounted for,
including maternal IQ, the Home Observation for Measure-
ment of the Environment Inventory (HOMEI) score (which
is a measure of the quality and quantity of stimulation and
support available to a child in the home environment),
maternal education, and birth weight.
Although ACCLPP has previously reviewed case manage-
ment of children with BLLs >10 µg/dL (2), this is the first
ACCLPP report to summarize scientific information relevant
to clinical management of children with BLLs <10 µg/dL.
This report also outlines recommendations from ACCLPP to
reduce childhood exposure to lead. Information on assessing
an environmental history and prevention strategies to decrease
exposures to lead have been published previously (2,3) and
are not included in this report.
Methods
ACCLPP provides advice and guidance to the U.S. Depart-
ment of Health and Human Services and CDC regarding new
scientific knowledge and technologic developments and their
practical implications for preventing childhood lead poison-
ing, and recommends improvements, as needed. ACCLPP
members are selected on the basis of their expertise in child-
hood lead poisoning prevention, blood lead screening, diag-
nosis, and medical management. ACCLPP liaisons represent
federal agencies and organizations with particular interest and
expertise in childhood lead poisoning prevention.
In October 2003, ACCLPP formed another workgroup
comprising three pediatricians and a CDC health scientist to
review the scientific literature regarding clinical management
options for BLLs <10 µg/dL and to outline recommendations
for clinical care providers. On the basis of its analysis, the
workgroup developed draft recommendations that were
reviewed and later adopted by ACCLPP in February 2006.
Results
Historic Trends in Children’s BLLs
in the United States
Since 1976, BLLs in U.S. children aged 1–5 years have
decreased substantially (Table 1), primarily as a result of poli-
cies that have reduced the dispersal of lead into the environ-
ment (9–12). However, many U.S. children continue to be
exposed to lead, primarily in their homes (13). Overt clinical
symptoms of lead intoxication are uncommon in the United
States, and lead evaluation and management strategies typi-
cally are intended to reduce the negative effects of lead on
central nervous system development in children who are clini-
cally asymptomatic. Because no safe BLL has been defined
(1), small reductions in population-level exposures to lead will
likely affect substantial numbers of children, and can be
expected to reduce the number of children affected by adverse
health outcomes associated with lead exposure (14).
Blood Lead Measurements
As with any biologic test, blood lead measurements entail
inherent uncertainties as a result of imprecise analytic tech-
niques and preanalytic variables (e.g., the specimen collection
process). However, the ratio of imprecision to measurement
value, particularly at BLLs <10 µg/dL, is relatively high. The
degree of inherent error in blood lead analysis varies by ana-
lytic methodology used, but whichever method is used, labo-
ratory performance depends on the procedures and skills of
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† A complimentary video or DVD entitled, “CDC Guidelines for Collecting
and Handling Blood Lead Samples—2004,” may be obtained from the
National Center for Environmental Health, Division of Laboratory Sciences,
Lead and Multielement Proficiency Program at e-mail ncehdls@cdc.gov.
the laboratory team (15,16). Federal regulations allow labora-
tories that perform blood lead testing to operate with a total
allowable error of ±4 µg/dL or ±10%, whichever is greater.
Consequently, at BLLs <10 µg/dL, a laboratory might oper-
ate within an error range of 8 µg/dL and still meet federal
proficiency standards. For example, an actual value of blood
lead at 7 µg/dL could be reported as being any value ranging
from 3 µg/dL to 11 µg/dL and still remain within the allow-
able error limit. A study of duplicate testing of identical blood
samples (all with a mean blood lead value <10 µg/dL) at eight
laboratories reported all results as <10 µg/dL and within
3 µg/dL of the overall mean for that specimen value (17). A
study conducted in 2006 indicated that the majority of blood
lead laboratories can achieve routine performance of ±2 µg/
dL at concentrations of <10 µg/dL without difficulty (18).
Blood lead test reliability also depends on adhering to blood
collection techniques that reduce sample contamination. Col-
lection of capillary blood from a fingerstick into a lead-free
collection device is an accepted method for obtaining a screen-
ing test (19–23) and contamination by lead from the skin
surface can be minimized if a protocol for proper capillary
specimen collection is followed (24).† However, because lead
levels from a capillary blood sample will vary from those of a
simultaneously drawn venous sample, elevated capillary
results should be confirmed with blood drawn by venipunc-
ture. Multiple studies have reported on the uncertainty intro-
duced by collecting capillary blood rather than venipuncture
at thresholds of 10 µg/dL or 15 µg/dL (19–23), but none has
examined the sensitivity or specificity of capillary methods at
thresholds <10 µg/dL.
Children’s BLL Patterns
BLLs increase quickly after an acute exposure, then gradu-
ally (over weeks) reach equilibrium with body stores of lead.
Lead is distributed unevenly within the human body; in chil-
dren, approximately 70% is stored in the bone compartment
(25–27). The residence time of lead in bone can be decades
(28). Thus, an elevated BLL will decline within a few weeks
to months after an acute exposure. However, for those chil-
dren with chronic lead exposure and, presumably higher bone
lead stores, the decline in BLL can take much longer (29).
Although bone lead levels can provide information regarding
past absorption of lead, measurements of lead in bone using
X-ray fluorescence instruments are available for research
purposes only.
A newborn infant’s BLL closely reflects that of the mother
(30). During 1999–2002, the geometric mean BLL for U.S.
women aged 20–59 years was 1.2 µg/dL, with 0.3% having a
BLL >10 µg/dL (12). Typically, as infants become more active
and increase their environmental exposures, BLLs increase.
Longitudinal studies of lead-exposed children have confirmed
an increase in BLLs beginning in late infancy, with a peak
level reached at age 18–36 months (6,31–33). No studies have
examined blood lead patterns specifically for children with
peak levels <10 µg/dL, although certain studies have included
children with levels this low. A study of children born during
1994–1995 in which >50% of the children had peak BLLs
<10 µg/dL reported an expected pattern in mean BLLs of
3.4 µg/dL at age 6 months, 9.7 µg/dL at age 24 months, and
5.8 µg/dL at age 61 months (6). A study of children born in
Boston during 1979–1981 identified mean BLLs of 7.2 µg/dL
at birth, and subsequent BLLs in these children remained rela-
tively constant (6.2 µg/dL at age 6 months, 6.8 µg/dL at age
24 months, and 6.4 µg/dL at age 57 months) (34–36). In
both studies, higher levels of lead in home environmental
samples were associated directly with higher BLLs in children
(35,37). In addition, the Boston study demonstrated an asso-
ciation between the occurrence of home renovation and
increased BLLs (35). The blood lead pattern for individual
children with BLLs <10 µg/dL varies depending on their en-
vironmental exposures (29). More research is needed to better
understand age-related patterns for BLLs that remain
<10 µg/dL. However, in clinical practice, even should addi-
tional research data become available, laboratory uncertainty
might interfere with a clinician’s ability to detect patterns for
individual children.
Once a high BLL has been established in a child, the time
required for the BLL to decline to <10 µg/dL can range from
months to years, depending on the duration and dose of
exposure. For example, for a group of children starting at a
BLL of 10–14 µg/dL and receiving case management services,
the mean time required for 50% to achieve a BLL <10 µg/dL
was 9 months (38). How much time is needed for BLLs
<10 µg/dL to decline in response to interventions is unknown.
Multiple studies have confirmed that blood lead measure-
ments vary seasonally. For example, a study conducted in
Boston reported that BLLs were highest in late June and low-
est in March (39). A Milwaukee study indicated that BLLs
were higher in the summer than in the winter (40). Some of
the variability (higher blood lead in summer) might result
from increased exposure to lead in dust and soil in summer
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months (41). Blood lead values for urban children are pre-
dicted to be 1–2 mg/dL higher in the summer than winter
months (42).
Association of BLL Patterns with
Developmental Outcomes
Although BLLs peak in early childhood, when young chil-
dren are especially vulnerable to lead, negative effects are
associated with lead exposure at any age. Multiple studies have
examined the effects of lead on children’s development out-
comes; in these studies, the ages at which BLLs were mea-
sured varied, as did the range of ages over which BLLs were
averaged (1–4). Statistically significant associations have been
identified between average BLLs over a specific period (e.g.,
0–5 years) and various adverse health outcomes (6,43–45);
other studies have reported statistically significant associations
with a single lead measurement at a specific age (e.g., prena-
tal, 24 months, and 6.5 years) or with a peak measurement
(6,31,46). Concurrent BLLs (i.e., those measured close to the
time of neurodevelopmental testing) might demonstrate stron-
ger associations with neurodevelopmental abilities than other
blood lead measures (6–8,32,47).
Lead has a continuing negative association with IQ as chil-
dren reach elementary school age. For children who partici-
pated in a trial of chelation therapy, a subsequent data analysis
indicated that BLLs measured concurrently with developmen-
tal testing were associated more closely with children’s cogni-
tive abilities than was a peak level at approximately age 2 years
(48). This association was stronger when children were tested
at age 7 years than at age 5 years, which underscores the
continuing need to reduce lead exposures after age 5 years.
Strategies to Enhance Children’s
Positive Developmental Outcomes
Although lead is a risk factor for developmental and behav-
ior problems, its presence does not indicate that these prob-
lems will necessarily occur. No characteristic developmental
pattern is attributable solely to the effects of lead, and mea-
sures of the effects of lead on children are imperfect. Thus, for
an individual child, neurobehavioral test performance might
indicate clinically-significant impairments related to lead
exposures but might not fully capture the array of negative
outcomes caused by lead (14). The effects of lead at levels
approaching 10 µg/dL might not be recognizable to either the
child’s family or clinician or be identified through
neurobehavioral testing. However, lead exposure might assume
greater importance for children with other environmental,
genetic, biologic, social, or demographic developmental risks
factors. Effects of exposures to lead at lower levels might not
be evident in testing of individual children but are best evalu-
ated on a communitywide basis (14).
Multiple factors influence a child’s development, including
how the child is treated by parents or other adult caregivers.
The child’s family and personal psychosocial experiences are
strongly associated with performance on neurodevelopment
measures and account for a greater proportion of the explained
variance in these measures than BLLs <10 mg/dL(2,43,45,49).
A child’s blood lead measurement is estimated to account for
2%–4% of variance in neurodevelopment measures (approxi-
mately 4%–8% of the explained variance) (2,43,50).
All children benefit from parental nurturing, regardless of
their BLL. For example, a child’s language skills are enhanced
by the amount of language addressed to the child (more is
better), combined with a predominant pattern of positive feed-
back (51). This pattern of parenting of children under age 3
years has been associated with enhanced language and cogni-
tive skills when children were tested in the third grade (52).
Thus, parents might help counteract the negative effects of
lead by providing a nurturing and enriched environment dur-
ing development. Studies to examine effects of lead have at-
tempted to control for this psychosocial factor by including
measures such as the HOMEI score (7). Although no studies
have specifically evaluated the effects of early intervention
programs on cognitive or behavioral outcomes in relationship
to children’s BLLs, several laboratory studies that applied a
nurturing environment to very young animals during lead
acquisition demonstrated the beneficial effect of the social
environment on ameliorating lead-related negative develop-
mental outcomes (53,54).
Early enrichment programs, although not tested specifically
in relation to BLLs, have been effective in improving cogni-
tive development and social competence of young children,
particularly infants from families with low levels of social or
economic resources (55). Research demonstrates that children
whose development has been delayed or who are at high risk
for delay benefit most from interventions applied at an early
age (56–58).
Strategies to Prevent and Reduce
Exposure to Lead
CDC and the American Academy of Pediatrics (AAP) rec-
ommend that preventive care for every child should include
obtaining an environmental history and identifying occupa-
tional lead exposure of household members (2,3,5). The
major sources of lead exposure among U.S. children are lead-
contaminated dust, deteriorated lead-based paint, and lead-
contaminated soil (37,59). Typically, lead contamination of
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water contributes less to a child’s lead burden than home and
soil sources (59); however, if additives to water (e.g., those
used in disinfection processes), are changed, the contribution
of lead contamination might be greater (60). The extent of
lead paint hazards (i.e., the presence of lead in an accessible
condition, such as deteriorated lead-based paint or lead-
contaminated dust or soil) on interior and exterior surfaces
and in soil is associated with increased BLLs in children (59).
Children also are exposed to nonhousing lead sources (e.g.,
lead in foods, cosmetics, pottery, folk remedies, and toys)
(2,3,61).
Home-Related Lead Exposure
An estimated 4.1 million homes in the United States (25%
of U.S. homes with children aged <6 years) have a lead-based
paint hazard (13). An estimated 68% of U.S. homes built
before 1940 have lead hazards, as do 43% of those built dur-
ing 1940–1959 and 8% of those built during 1960–1977;
estimates are higher for homes in the Northeast and Midwest
and for homes in which young children reside (13). Despite
considerable attention and resources from federal, state, and
local agencies and advocacy groups, publicly available fund-
ing has not been able to provide sufficient resources to elimi-
nate all lead paint hazards from U.S. homes. Publicly funded
home inspections are most often limited to homes of children
with elevated BLLs; the blood lead threshold value that
prompts an inspection varies by state or municipality (62). In
addition, even when a child’s elevated BLL triggers an inspec-
tion, public funding for repairs to reduce or eliminate identi-
fied lead hazards typically is not available.
Since 1991, lead-hazard–control grant programs through
the U.S. Department of Housing and Urban Development’s
(HUD) Office of Healthy Homes and Lead Hazard Control
(OHHLHC) have provided funding for local and state agen-
cies to reduce lead and other environmental hazards in pri-
vately owned low-income housing. In 2005, OHHLHC
allocated $139 million for this purpose, administered through
seven different grant types. Other federal programs provide
funding to eliminate lead-based paint hazards in federally
assisted housing. Typically, the focus of these programs is on
housing rehabilitation and activities that remediate lead haz-
ards after children are identified with elevated BLLs, but HUD-
funded local programs also now include primary prevention
interventions that control or eliminate lead before children
are exposed.
CDC is working with HUD, the U.S. Environmental Pro-
tection Agency (EPA), state and local health department lead
poisoning prevention grantees, and child health and environ-
mental justice advocates to promote primary prevention strat-
egies to reduce exposure to lead (1,63,64). In addition to their
traditional role of providing services to children with elevated
BLLs, CDC-funded state and local lead poisoning preven-
tion programs have been charged with implementation of
housing-based primary prevention strategies in their jurisdic-
tions. This moves beyond their traditional role of providing
services to children with elevated BLLs and involves develop-
ing responses to local risks and a focus on identifying and
remediating housing-based lead hazards. ACCLPP recommen-
dations for essential elements for state and local primary
prevention plans have been published previously (63), and
strategies that have been implemented at the state and local
levels to address the problem also have been outlined previ-
ously (64). As ACCLPP noted, implementation of state and
local primary prevention plans will require 1) targeting the
highest risk areas, populations, and activities; 2) fostering
political will for jurisdictions to provide an adequate level of
funding; 3) expanding resources for housing remediation; iden-
tification and correction of lead hazards; and 4) establishing a
regulatory infrastructure to create and maintain lead-safe hous-
ing and to support the use of lead-safe construction work prac-
tices (63,65). Links to state and local health department web
sites, which include their primary prevention plans, are avail-
able at http://www.cdc.gov/nceh/lead/grants/contracts/
CLPPP%20map.htm.
Certain state and local health departments initiate case
management services and home inspections when BLLs reach
10 mg/dL. As more primary prevention strategies are imple-
mented, the number of health departments pursuing home
inspections when BLLs reach 10 µg/dL will likely increase.
Certain communities have developed online registries to help
parents identify homes that are lead-safe or that have lead
hazards (66).
Steps to Identify and Safely Reduce Lead-
Based Paint Hazards in Homes
Lead-based paint hazards in homes are important sources
of lead exposure. Preventive actions can be implemented to
identify and address these hazards. Tenants can request a copy
of all lead testing reports for housing sites from landlords at
any time. Their landlord should have been provided with such
information when they purchased the building; compliance
with a tenant request for a copy of all lead testing reports is
required by federal law (67). In addition, federal regulations
require sellers and landlords 1) to disclose the possible pres-
ence of lead-based paint in any pre-1978 property and 2) to
provide information on known lead-based paint and lead-based
paint hazards at the time final agreements are signed on the
purchase or rental of most housing built before 1978 (e.g., by
providing results of any past evaluations of the property for
lead) (67). Prospective buyers or renters have the opportunity
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BOX. Tips to reduce lead-based paint and lead-based paint
hazards
• Concentration of lead is generally highest in lead-based
paint on exterior surfaces.
• Among interior surfaces, windows are most likely to have
highest lead content.
• Interior surfaces can become contaminated from
exterior sources or common areas.
• Lead-based paint on impact/friction surfaces (e.g.,
windows, doors, floors) deteriorates as paint is disturbed
during use.
• Lack of a deteriorated surface does not ensure absence
of lead-contaminated dust, although it lowers the risk.
• Renovation, remodeling, and repainting can significantly
increase lead dust levels.
• Vacuum methods (using a traditional vacuum or a high-
energy particulate air [HEPA] filtered vacuum) will not
lower lead levels on soiled carpets or upholstery far
enough to achieve safe levels.
• Creating smooth cleanable surfaces helps achieve lower
dust lead levels.
• Treatments addressing lead-contaminated exterior dust/
soil and building exterior lead hazards will contribute
to lower lead dust in entryway and home interior
locations.
• Safely addressing interior, exterior, and soil lead hazards
in an integrated manner will be most beneficial in
establishing lasting, lead-safe environments.
to arrange for a lead inspection or risk assessment by a quali-
fied professional at their own expense; buyers have up to 10
days to check for lead. Further, the law requires sellers, land-
lords, and renovators to provide buyers, renters, and those
hiring renovators with an EPA-approved pamphlet, “Protect
Your Family from Lead in Your Home” (68). To protect their
children from lead, parents might choose not to buy or rent a
property or to negotiate remediation of identified lead haz-
ards. However, landlords or homeowners might not know
whether their property has any lead-based paint or lead hazards.
Lead-based paint hazards are likely to be present in older
homes; all homes built before 1978 should be presumed
either to have a lead hazard present or to contain intact lead-
based paint unless a licensed lead inspector has determined
otherwise. Lack of a deteriorated surface decreases the likeli-
hood of lead-contaminated dust being present but does not
ensure its absence. Knowledge of general characteristics of lead-
based paint and lead-based paint hazards and their control
might help parents to understand their home better (Box)
(69–73).
Screening for lead dust hazards through dust wipe testing
(i.e., standardized collection of dust by wiping surfaces and
measurement of lead collected) can help identify areas of con-
cern. Because lead is not distributed uniformly within a home,
wipe testing neither ensures absence of lead hazards at loca-
tions in the home that were not tested, nor does it ensure
future protection from lead dust hazards if lead-painted sur-
faces subsequently deteriorate or are disturbed. Potential
sources of future contamination include lead-containing paint
on areas disturbed by impact/friction (e.g., windows, doors,
and floors) and the interior migration of lead-contaminated
exterior dust and soil (70). However, identifying lead dust
hazards in the home is a first step toward protecting children
and might help parents lower lead dust levels in their homes
(74). Proper training is recommended for those collecting dust
wipes to focus tests on areas at highest risk (63). Parents or
property owners who wish to perform dust wipe sampling
may consult their local health or housing departments for
advice regarding sampling procedures, interpretation of results,
and further actions based on results.
For a lead-safe environment to be established in older build-
ings, repair of lead hazards and careful attention to mainte-
nance is necessary. However, local ordinances typically do not
require action until a child’s BLL is elevated, and property
owners might be unaware of lead hazards or ignore them. Pri-
mary prevention is possible only if the focus on safety in older
housing is increased and lead hazards are repaired proactively
before a child is exposed. In all pre-1978 properties, owners
should use lead-safe work techniques when implementing rou-
tine maintenance to decrease the likelihood of lead hazards
developing in a home.
Home renovation or repair is known to be a risk factor for
increasing or elevated BLLs, principally through exposures to
the dust residue generated during the work (35,75–77). All
contractors who perform repair and renovation work in older
housing should be trained in lead-safe work practices and com-
ply with any state and local requirements governing work with
lead paint hazards (78). Property owners doing work them-
selves should seek expert advice and training to protect them-
selves and their families (79,80). Lead-safe work practices
include 1) relocating families when the work warrants, 2) mini-
mizing the amount of dust created, 3) containing dust in the
work area, 4) cleaning up completely, 5) disposing of waste
safely, and 6) performing clearance testing (i.e., testing of dust
for lead after site clean up) to ensure that residual lead levels
do not exceed EPA standards (81). Families with young chil-
dren should be restricted from work areas until clearance test-
ing has been performed and the area has been judged safe.
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In previous evaluation studies, lead dust clearance standards
were not low enough to protect children from increased expo-
sures to lead-contaminated dust after lead hazard remediation;
as a result, after home repairs, BLLs of children with
preremediation BLLs <25 µg/dL increased (82). In 2001, the
EPA’s lead dust clearance standards were lowered to 40 µg/ft2
for floors, 250 µg/ft2 for windowsills, and 400 µg/ft2 for win-
dow wells (81). No studies have evaluated if these lower clear-
ance levels protect children whose BLLs are <10 µg/dL
adequately from ongoing lead exposure. A cross-sectional study
estimated that 20% of children with a current exposure to
floor dust-lead at 40 µg/ft2 will have BLLs >10 µg/dL (83).
A study conducted in 1994–1999 in 14 U.S. cities involv-
ing 2,682 pre-1978 homes demonstrated reductions in lead
dust levels and fall in children’s BLLs when lead-safe work
practices were used during remediation efforts (69,84,85). The
study applied lead dust clearance standards substantially less
stringent than those currently in place, although clearance floor
dust lead levels were generally low (geometric mean: 16 µg/ft2)
(86). However, among the 869 children in this study who
were tested within 4 months before home lead remediation
and approximately 7 weeks after remediation, 81 (9.3%) had
a clinically significant increase (>5 µg/dL) in BLLs; infants,
children of less-educated mothers, and children from homes
with higher numbers of preintervention exterior lead hazards
were at highest risk (87). Dust lead levels at clearance were
not associated significantly with an increase in BLLs. The study
listed multiple types of exposures (e.g., other homes, parental
job exposures) that might have accounted for increasing BLLs,
but these were not evaluated systematically. Although lead
remediation work reduced overall lead dust and BLLs, the
finding that >9% of children had a rise in BLL of >5 µg/dL
underscores the need to maintain a high level of vigilance to
ensure that children are protected when homes or apartments
undergo renovation and repair.
Educational Strategies
Lead exposure prevention strategies for children with BLLs
<10 µg/dL typically focus on education and promotion of
home cleanliness, without further identifying lead hazards or
repairing them. Providing low-income parents with lead-
related education via video in a pediatric office has been dem-
onstrated to be effective in increasing knowledge and parental
report of compliance with lead prevention actions in the home
(88). No studies have evaluated office-based education with
accompanying in-home strategies or used children’s BLLs as
the outcome measure for an office-based education strategy.
Studies of children at high risk that applied intervention
strategies in the home or community have demonstrated the
failure of education and nonprofessional cleaning conducted
alone (i.e., in the absence of other measures to reduce lead
exposure) in preventing the development of BLLs >10 µg/dL
(2,89–91). Few studies have applied prospective designs that
included control groups. One study indicated that a highly
intensive education program starting at birth and lasting for
³3 years (28 sessions) delivered by community members low-
ered the risk of BLLs ³10 µg/dL 34%, but this result was not
statistically significant (92). Repeated in-home lead preven-
tion education, even when accompanied by complimentary
supplies of cleaning materials, was ineffective in lowering the
incidence of elevated BLLs (93,94). A review of four studies
(90) involving caregiver education (94,95) and professional
house cleaning (96,97) indicated that such low-cost interven-
tions reduced the overall proportion of children with BLLs
>15 µg/dL or >20 µg/dL, but the effect on mean BLLs was
not statistically significant (p>0.05).
Intensive cleaning regimens reduce lead levels; in one study,
biweekly professional cleaning resulted in a 17% decrease in
mean BLLs after 1 year (96). However, the benefit of such
intense and repeated cleaning was limited to homes without
carpets (98). Intense cleaning can be used without subjecting
children to a risk for increased lead exposure from unsafe
repair methods (i.e., those not in compliance with lead-safe
work practices). A single intensive cleaning alone does reduce
levels of lead in dust by 32% to 93% depending on surface
tested and starting lead concentration (99), but reaccumulation
occurs within 3–6 months (100,101).
A study that involved children with BLLs 15–19 µg/dL com-
pared the effects of nurse home visits (five visits during 1 year)
accompanied by lead dust tests with those of usual care (one
or two visits by an outreach worker during 1 year) (74). After
1 year, dust lead levels were significantly lower (p<0.05) in
homes where lead dust tests had been conducted during
intervention than in usual care homes. This finding suggests
that dust testing might help parents better understand lead
hazards and take action to lower them. However, changes in
dust lead were not mirrored by changes in BLLs in this group
of children with elevated BLLs.
Blood Lead Screening Strategies
CDC (102) and AAP (3) have recommended that health-
care providers conduct blood lead tests on children enrolled
in Medicaid and those identified as being at risk on the basis
of the state or local screening plan or the risk assessment pro-
cess. Federal policy requires that all children enrolled in Med-
icaid receive screening blood lead tests at ages 12 and 24
months and that blood lead screening be performed for chil-
dren aged 36–72 months who have not been screened previ-
ously (103). Despite this, blood lead screening rates for
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Medicaid children have been low (<20%) (104) and in cer-
tain areas remain at approximately 20% (105). In 1997, CDC
requested state and local health officials to use local
communitywide data (e.g., BLL prevalence, housing age, and
poverty status) to develop plans for blood lead screening for
their jurisdictions and provide them to clinicians (102). These
plans recommend either universal or targeted blood lead screen-
ing. State and local screening plans are available at http://
www.cdc.gov/nceh/lead/grants/contacts/CLPPP%20Map.htm.
Targeted screening strategies enable clinicians to assess risks
for individual children and recommend blood lead testing for
a subset of children in the jurisdiction thought to be at
increased risk for lead exposure. CDC recommends that risk
evaluations be conducted on the basis of such factors as resi-
dence in a geographic area, membership in a group at high
risk, answers to a personal-risk assessment questionnaire (which
might include local factors such as cultural practices or prod-
ucts, such as herbal remedies, traditional cosmetics or imported
spices), or other risk factors relevant to the jurisdiction (102).
CDC recommends that locally developed targeted risk
assessment and blood lead screening strategies be applied at
ages 1 and 2 years (102). Children aged 36–72 months who
have been identified as being at risk and who have not been
screened previously also should receive a blood lead test (102).
For clinicians in areas that lack a state or local screening plan,
CDC recommends that a blood lead test be performed on all
children at ages 1 and 2 years and on children aged 36–72
months who have not been screened previously (102).
Because lead exposures might change with a child’s devel-
opmental progress (e.g., walking or reaching window sills) or
as a result of external factors (e.g., family relocation or home
remodeling), two routine screenings are recommended (at
approximately ages 1 and 2 years). Among children in Chi-
cago at high risk with BLLs <10 µg/dL at age 1 year, 21% had
a BLL of >10 µg/dL when tested again at age >2 years (103).
This report does not change current CDC recommendations
in ages for routine blood lead testing. However, certain
local health departments (e.g., those in Chicago, Illinois; New
York, New York; and Philadelphia, Pennsylvania) recommend
blood lead screening at younger ages or more frequently (106–
108). For example, these departments recommend BLL test-
ing starting at ages 6–9 months in high risk areas, blood lead
testing at more frequent intervals (e.g., every 6 months) for
children aged <2 years, or the provision of additional educa-
tion and more rapid follow-up blood lead testing for children
aged <12 months with BLLs 6–9 µg/dL.
Personal Lead Risk Assessment
Questionnaires
The effectiveness of personal risk assessment questionnaires
in identifying children with elevated BLLs has been
documented in the scientific literature (Table 2) (109–125).
However, no studies have evaluated the performance of these
questionnaires at cut-off levels <10 µg/dL or their effective-
ness in directing counseling or in identifying lead hazards in
the home. When applied in consecutive samples of patients
in clinical settings, the sensitivity of such questionnaires to
identify children with BLLs >10 µg/dL varies considerably by
population (109–128). In certain studies, the sensitivity
improved if higher cut-off levels were used in the analysis
(103,115,119,120) or if the questions used were developed
specifically for the population tested (113,116,117,119,120,122).
In general, to identify approximately 80% of children with
BLLs >10 µg/dL, a blood test had to be performed for more
than half of those children whose risk factors for lead expo-
sure were assessed using a questionnaire. Multiple studies in
populations with low (109,110,112–114, 127,128) or high
(123,124) prevalence for elevated BLLs concluded that risk
assessment questionnaires were not effective in their clinical
settings.
Future Research Needs
Further study is needed to assess the effects of BLLs <10 µg/
dL on children. Such research will entail following large and
diverse populations, with careful attention to potential con-
founders and measurements of social factors. Additional
research also is needed to evaluate the effectiveness of strate-
gies to lower exposures to lead. This should include research
on the effectiveness of strategies applied in the medical office
and home and those that provide interventions through medi-
cal, public health, and environmental means.
Blood lead screening strategies should be evaluated to
determine the most appropriate ages for screening and the
utility of screening strategies applied at the community level.
Evaluations of lead surveillance strategies should test ways to
identify changing patterns of environmental risks and sub-
populations exposed to established and emerging sources of
lead. In addition, better ways should be identified to alert
public and clinical health-care professionals of changes in
exposure sources and patterns and to enhance their response
to such changes by increased surveillance and blood lead moni-
toring of populations identified as being at increased risk for
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TABLE 2. Sensitivity and specificity of lead risk assessment questionnaires to predict blood lead levels (BLLs) of >10 µg/dL
among patient samples — United States, 1994–2003
Type of lead
Prevalence in exposure risk
Sample study sample of assessment At cut-off value of >10 µg/dL
Location characteristics % BLLs >10 µg/dL questions Sensitivity Specificity
Alaska* Medicaid 0.6 Modified 0.83 0.39
California† Medicaid 2.0 CDC 0.46 0.74
Suburban Chicago§ Private practices 2.2 CDC 0.69 0.70
Modified 0.86 0.53
Arizona¶ Navajo Reservation 2.2 CDC 0.43 0.74
New York** Rural 2.3 CDC 0.25 0.49
Modified 0.50 NR††
Denver§§ Community health centers 2.9 Modified 0.60 0.36
Illinois¶¶ Low-risk ZIP codes 3.5 Modified 0.75 0.39
Wisconsin*** HMO Clinic A 5.4 CDC 0.77 0.37
Modified 1.00 0.42
Ohio††† Mixed sample 5.6 CDC 0.85 0.42
Modified 0.92 0.57
San Francisco§§§ Mixed sample 5.8 CDC 0.87 0.75
California¶¶¶ Public clinics 6.1 CDC 0.30 0.80
Modified 0.90 0.37
New York**** Rural 8.4 CDC 0.75 0.31
Modified 0.88 0.44
Vermont†††† Birth certificate cohort 9.0 CDC 0.63 0.57
Minnesota§§§§ HMO 11.8 Modified 0.90 0.17
Modified brief 0.77 0.48
Illinois¶¶ High-risk ZIP codes 12.1 Modified 0.74 0.27
Vermont†††† Medicaid 14.9 CDC 0.67 0.50
Wisconsin*** HMO Clinic B 16.8 CDC 0.64 0.32
Modified 0.91 0.43
Massachusetts¶¶¶¶ Urban, high risk 21.8 CDC 0.70 0.32
Philadelphia area***** Privately insured 29.1 CDC 0.40 0.60
Rochester, New York††††† Primarily Medicaid 28§§§§§ CDC 0.70 0.49
* Source: Robin LF, Beller M, Middaugh JP. Statewide assessment of lead poisoning and exposure risk among children receiving Medicaid services
in Alaska. Pediatrics 1997;99:e9. Available at http://www.pediatrics.org/cgi/content/full/99/4/e9.
† Source: CDC. Blood lead levels among children in a managed-care organization—California, October 1992–March 1993. MMWR 1995;44:627–35.
§ Source: Binns HJ, LeBailly SA, Poncher J, Kinsella TR, Saunders SE, Pediatric Practice Research Group. Is there lead in the suburbs? Risk
assessment in Chicago suburban pediatric practices. Pediatrics 1994;93:164–71.
¶ Source: Kazal LA Jr. The failure of CDC screening questionnaire to efficiently detect elevated lead levels in a rural population of children. J Fam
Practice 1997;45:515–8.
** Source: Muniz MA, Dundas R, Mahoney MC. Evaluation of a childhood lead questionnaire in predicting elevated blood lead levels in a rural
community. J Rural Health 2003;19:15–9.
†† Not reported.
§§ Source: France EK, Gitterman BA, Melinkovich P, Wright RA. The accuracy of a lead questionnaire in predicting elevated pediatric blood lead levels.
Arch Pediatr Adolesc Med 1996;150:958–63.
¶¶ Source: Binns HJ, LeBailly SA, Fingar AR, Saunders S. Evaluation of risk assessment questions used to target blood lead screening in Illinois.
Pediatrics 1999;103:100–6.
*** Source: Rooney BL, Hayes EB, Allen BK, Strutt PJ. Development of a screening tool for prediction of children at risk for lead exposure in a
midwestern clinical setting. Pediatrics 1994;93:183–7.
††† Source: Striph KB. Prevalence of lead poisoning in a suburban practice. J Fam Pract 1995;41:65–71.
§§§ Source: Tejeda DM. Wyatt DD. Rostek BR. Solomon WB. Do questions about lead exposure predict elevated lead levels? Pediatrics 1994;93:192–4.
¶¶¶ Source: Snyder DC, Mohle-Boetani JC, Palla B, Fenstersheib M. Development of a population-specific risk assessment to predict elevated blood
lead levels in Santa Clara County, California. Pediatrics 1995;96:643–8.
**** Source: Schaffer SJ, Kincaid MS, Endres N, Weitzman M. Lead poisoning risk determination in a rural setting. Pediatrics 1996;97:84–90.
†††† Source: Paulozzi LJ, Shapp J, Drawbaugh RE, Carney JK. Prevalence of lead poisoning among two-year-old children in Vermont. Pediatrics
1995;96:78–81.
§§§§ Source: Rolnick SJ. Nordin J, Cherney LM. A comparison of costs of universal versus targeted lead screening for young children. Environ Research
1999;80:84–91.
¶¶¶¶ Source: Dalton MA, Sargent JD, Stukel TA. Utility of a risk assessment questionnaire in identifying children with lead exposure. Arch Pediatr Adolesc
Med 1996;150:197–202.
***** Source: Casey R, Wiley C, Rutstein R, Pinto-Martin J. Prevalence of lead poisoning in an urban cohort of infants with high socioeconomic status.
Clin Pediatr 1994;33:480–4.
††††† Source: Schaffer SJ, Szilagyi PG, Weitzman M. Lead poisoning risk determination in an urban population through the use of a standardized
questionnaire. Pediatrics 1994;93:159–63.
§§§§§ Data not available to add a decimal place.
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exposure. Additional studies might provide data that can be
used to improve laboratory methods and performance moni-
toring. This will require developing criteria to evaluate indi-




• Provide anticipatory guidance to parents of all young chil-
dren regarding sources of lead and help them identify
sources of lead in their child’s environment. Obtain an
environmental and family occupational history and edu-
cate parents about the most common sources of child-
hood lead exposure for their child and in their community.
Encourage parents to identify lead hazards and sources in
their homes and reduce their child’s potential for
exposure to lead, including the safe implementation of
control measures before BLLs increase. Warn parents
about the dangers poised by unsafe renovation methods
and to be cognizant of the possibility of new and reemerg-
ing sources of lead in children’s environments. Direct par-
ents to local, state, and federal agencies and organizations
for information, particularly concerning methods to iden-
tify and safely repair lead hazards (Appendix).
• Help parents to understand the uncertainty of a blood
lead value and potential reasons for its fluctuation,
including error introduced by the sampling methods and
laboratory-, age-, and season-related exposures.
• Assess all children for developmental and behavior status
and seek further evaluation and therapy to reduce devel-
opmental or behavioral problems, as necessary. Consider
the potential influences of lead when conducting devel-
opmental screening. For children with multiple develop-
mental risk factors, which might include lead exposures,
consider more frequent developmental surveillance or
conduct more extensive developmental evaluations.
• Discuss with parents the potential impact of lead on child
development and promote strategies that foster optimum
development, including encouraging parents to influence
their child’s development positively by providing nurtur-
ing and enriching experiences. For all children from eco-
nomically and socially low-resource families living in areas
where exposure to lead is likely, promote participation in
early enrichment programs regardless of the child’s BLL.
• Whenever possible, utilize laboratories that can achieve
routine performance of ±2 µg/dL for blood lead analysis.
Evaluate laboratory performance by reviewing the
laboratory’s quality control chart or statistical quality
control summary.
• Review office procedures and policies to ensure that lead
exposure risk assessment or blood lead screening is per-
formed on all children as required by state or local health
officials or as recommended by CDC. Consider the child’s
age, season of testing, and exposure history when decid-
ing when to obtain follow-up blood lead tests. For a child
whose BLL is approaching 10 µg/dL, more frequent blood
lead screening (i.e., more than annually) might be appro-
priate, particularly if the child is aged <2 years old, was
tested at the start of warm weather when BLLs tend to
increase, or is at high risk for lead exposures.
• Perform a diagnostic blood lead test on all children sus-
pected of having lead exposure or an elevated BLL and
institute the recommended management guidelines if a
child’s BLL increases to >10 µg/dL.
• Become informed about lead exposure prevention strate-
gies of local or state health departments and partner with
public health agencies, community groups, and parents
to work toward establishing lead-safe environments in
homes and schools for all children and the reduction of
exposure to lead from all sources. Advocate for the
expansion of services that foster lead poisoning primary
prevention.
For Government Agencies
• Increase efforts to resolve lead-based paint hazards safely
before children are exposed.
• Expand services that promote lead poisoning primary
prevention and develop systems that enable clinicians and
parents to learn about such services.
• Develop and implement strategies to encourage the safe
elimination of lead hazards in properties using trained
workers and lead-safe work practices, in compliance
with federal, state, and local regulations.
• Establish jurisdictional policies that mandate ensuring lead
safety in housing and enforce these mandates.
• Develop and apply systematic approaches to prevent
exposures to even small amounts of lead in food or con-
sumer products, particularly when safer alternatives are
available.
• Promote implementation of state and local primary pre-
vention plans that target areas, populations, and activi-
ties of highest risk; foster political will; expand resources
for housing remediation; identify and correct lead haz-
ards; and establish a regulatory infrastructure to create
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and maintain lead-safe housing and support the use of
lead-safe construction work practices.
• Expand the availability of and promote the use of early
enrichment programs for all children from economically
and socially low-resource families living in areas where
exposure to lead is likely.
• Promote and fund research that will further evaluate the
effects of lead in blood at levels <10 µg/dL and evaluate
strategies to identify and reduce exposure or the potential
for exposure to lead, including strategies applied in medi-
cal offices and in homes.
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Appendix: Guide to Resources for Parents
Agency/Organization Specific resource(s) Contact information
National Lead Information Center
U.S. Consumer Product Safety Commission
U.S. Department of Health and Human
Services, CDC, Lead Poisoning Prevention
Branch
U.S. Department of Housing and Urban
Development, Office of Healthy Homes and
Lead Hazard Control
U.S. Environmental Protection Agency,
Office of Pollution Prevention and Toxics
Alliance for Healthy Homes
The National Center for Healthy Housing
National Library of Medicine, National Institutes
of Health
Multiple general publications
Protect Your Family from Lead in Your Home
Product-specific information
Multiple reports, recall notices, and safety alerts
Questions and answers
Fact sheets
Lead screening plans by state and area· Links
to other sources
Lead Paint Safety: A Field Guide for Painting,
Home Maintenance, and Renovation Work
Caution: Lead Paint Handle With Care
Lead Paint Can Poison: Learn The Facts
Other materials
Lead in Your Home: A Parent’s Reference Guide
Reducing Lead Hazards When Remodeling
Your Home
Protect Your Family From Lead in Your Home
Is There Lead in my Drinking Water?
Lead Poisoning and Your Children
Other materials
Lead Safety Tips for Tenants
Lead-Safe Painting and Renovation
Links to other sources
A Guide to Working Safely With Residential Paint
Links to other sources
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